Skip to main content
Premium Trial:

Request an Annual Quote

Genetron Health Receives Nasdaq Noncompliance Notice

NEW YORK – Genetron Health said Wednesday that it was notified by the Nasdaq on May 17 that the closing bid price for its American depositary shares had fallen below the required minimum bid price of $1.00 per share for 30 consecutive business days.

Pursuant to Nasdaq rules, the Chinese cancer molecular profiling company now has 180 calendar days, or until Nov. 13, to regain compliance under the Nasdaq listing rules, meaning its ADS bid price has to be at least $1.00 for a minimum of 10 consecutive business days.

Genetron said that its business operations are not affected by the Nasdaq notification letter and that it plans to monitor its ADS bid price closely and "take all reasonable measures" in order to regain compliance.

Earlier this year, the Beijing-based firm had already regained compliance with Nasdaq's minimum bid price requirement after getting a noncompliance notice last November.

In Wednesday morning trading on the Nasdaq, Genetron's shares were down 2 percent at $.88.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.